High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor study

Vascular Health and Risk Management

Volumn 13, Issue , 2017, Pages 127-137

  Goss, Franz ^a   Brachmann, Johannes ^b   Hamm, Christian W ^c   Haerer, Winfried ^d   Reifart, Nicolaus ^e   Levenson, Benny ^f  

^a Kardiologie Alter Hof   (Germany)

^b KLINIKUM COBURG   (Germany)

^c KERCKHOFF HEART CENTER   (Germany)

^d Herzklinik Ulm   (Germany)

^e Kardiologische Praxis Prof Reifart and Partner   (Germany)

^f Kardiologische Gemeinschaftspraxis und Herzkatheterlabor Berlin Charlottenburg   (Germany)

Author keywords

Compliance; Feedback; Mortality; Myocardial infarction; Patient education; Patient management; Patient oriented outcomes; Quality of life; Therapy adherence

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOLOGIST; CARDIOVASCULAR MORTALITY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG UTILIZATION; DUAL ANTIPLATELET THERAPY; FEMALE; FOLLOW UP; GERMANY; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICATION COMPLIANCE; MORBIDITY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS; AGED; AMBULATORY CARE; ANGINA, UNSTABLE; ATTITUDE TO HEALTH; CAUSE OF DEATH; COOPERATION; INTERDISCIPLINARY COMMUNICATION; MIDDLE AGED; MORTALITY; NON-ST ELEVATED MYOCARDIAL INFARCTION; PATIENT CARE; PATIENT EDUCATION; PROGRAM EVALUATION; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; ST ELEVATION MYOCARDIAL INFARCTION; TIME FACTOR; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; AMBULATORY CARE; ANGINA, UNSTABLE; CARDIOLOGISTS; CAUSE OF DEATH; COOPERATIVE BEHAVIOR; FEMALE; GERMANY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NON-ST ELEVATED MYOCARDIAL INFARCTION; OFFICE VISITS; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PLATELET AGGREGATION INHIBITORS; PROGRAM EVALUATION; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ST ELEVATION MYOCARDIAL INFARCTION; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME;

EID: 85019760476     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S119490     Document Type: Article

References (38)

1. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014;35(42):2950-2959.
2. Freisinger E, Fuerstenberg T, Malyar NM, et al. German nationwide data on current trends and management of acute myocardial infarction:discrepancies between trials and real-life. Eur Heart J. 2014;35(15):979-988.
3. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267-315.
4. Goldberg RJ, Currie K, White K, Brieger D, Steg PG, Goodman SG, et al. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2004;93(3):288-293.
5. Fox KA, Carruthers KF, Dunbar DR, et al. Underestimated and underrecognized:the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). European Heart J. 2010;31(22):2755-2764.
6. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(23):2999-3054.
7. Task Force on the management of STseamiotESoC, Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569-2619.
8. Budaj A, Brieger D, Steg PG, et al. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2003;146(6):999-1006.
9. Bhatt DL, Roe MT, Peterson ED, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004;292(17):2096-2104.
10. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;(2):CD000011.
11. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012; 125(9):882-7e1.
12. Mansoor SM, Krass I, Aslani P. Multiprofessional interventions to improve patient adherence to cardiovascular medications. J Cardiovasc Pharmacol Ther. 2013;18(1):19-30.
13. Van de Werf F, Ardissino D, Bueno H, et al. Acute coronary syndromes:considerations for improved acceptance and implementation of management guidelines. Expert Rev Cardiovasc Ther. 2012;10(4):489-503.
14. Ciccone MM, Aquilino A, Cortese F, et al. Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo). Vasc Health Risk Manag. 2010;6:297-305.
15. Stange D, Kriston L, von-Wolff A, Baehr M, Dartsch DC. Reducing cardiovascular medication complexity in a German university hospital:effects of a structured pharmaceutical management intervention on adherence. J Manag Care Pharm. 2013;19(5):396-407.
16. Luders S, Schrader J, Schmieder RE, Smolka W, Wegscheider K, Bestehorn K. Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial. Eur J Cardiovasc Prev Rehabil. 2010;17(3):271-279.
17. Steg P, James S, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569-2619.
18. van Dalem J, Krass I, Aslani P. Interventions promoting adherence to cardiovascular medicines. Int J Clin Pharm. 2012;34(2):295-311.
19. Costa E, Giardini A, Savin M, et al. Interventional tools to improve medication adherence: review of literature. Patient Prefer Adherence. 2015;9:1303-1314.
20. Dorler J, Alber HF, Altenberger J, et al. Primary percutaneous intervention of ST-elevation myocardial infarction in Austria: Results from the Austrian acute PCI registry 2005-2007. Wien Klin Wochenschr. 2010;122(7-8):220-228.
21. De Luca L, Leonardi S, Cavallini C, et al. Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study. Eur Heart J Acute Cardiovasc Care. 2015;4(5):441-452.
22. Bueno H, Danchin N, Tafalla M, Bernaud C, Annemans L, Van de Werf F. EPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: rationale, design, and baseline characteristics. Am Heart J. 2013;165(1):8-14.
23. Hanssen M, Cottin Y, Khalife K, et al. French Registry on Acute STelevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010. Heart. 2012;98(9):699-705.
24. Damman P, Varenhorst C, Koul S, et al. Treatment patterns and outcomes in patients undergoing percutaneous coronary intervention treated with prasugrel or clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR]). Am J Cardiol. 2014;113(1):64-69.
25. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a metaanalysis. Med Care. 1998;36(8):1138-1161.
26. Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011.
27. Lambert-Kerzner A, Del Giacco EJ, Fahdi IE, et al. Patient-centered adherence intervention after acute coronary syndrome hospitalization. Circ Cardiovasc Qual Outcomes. 2012;5(4):571-576.
28. Lambert-Kerzner A, Havranek EP, Plomondon ME, et al. Perspectives of patients on factors relating to adherence to post-acute coronary syndrome medical regimens. Patient Prefer Adherence. 2015;9:1053-1059.
29. Loh JP, Pendyala LK, Kitabata H, et al. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction). Am J Cardiol. 2014;113(11):1794-1801.
30. Amann U, Kirchberger I, Heier M, et al. Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA/ KORA Myocardial Infarction Registry. Clin Res Cardiol. 2014;103(8):655-664.
31. Barrabes JA, Bardaji A, Jimenez-Candil J, et al. Prognosis and management of acute coronary syndrome in Spain in 2012: the DIOCLES study. Rev Esp Cardiol (Engl Ed). 2015;68(2):98-106.
32. Ferreira-Gonzalez I, Permanyer-Miralda G, Marrugat J, et al. MASCARA (Manejo del Sindrome Coronario Agudo. Registro Actualizado) study. General findings. Rev Esp Cardiol. 2008;61(8):803-816.
33. Puymirat E, Schiele F, Steg PG, et al. Determinants of improved one-year survival in non-ST-segment elevation myocardial infarction patients:insights from the French FAST-MI program over 15 years. Int J Cardiol. 2014;177(1):281-286.
34. Brown JP, Clark AM, Dalal H, Welch K, Taylor RS. Patient education in the management of coronary heart disease. Cochrane Database Syst Rev. 2011;(12):CD008895.
35. Clark AM, McAlister FA, Hartling L, Vandermeer B. Randomized Trials of Secondary Prevention Programs in Coronary Artery Disease: A Systematic Review. Rockville, MD: Agency for Healthcare Research and Quality; 2005.
36. Delgado-Rodriguez M, Llorca J. Bias. J Epidemiol Community Health. 2004;58(8):635-641.
37. Jukema JW, Lettino M, Widimský P, et al. Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe:overview and methodological considerations. Eur Heart J Cardiovasc Pharmacother. 2015;1(4):232-244.
38. Ackroyd SH, Hughes JA. Data Collection in Context. New York, NY:Longman; 1992.